Meredyth L. Wilkinson
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Spatial transcriptomic analysis of muscle biopsy from patients with treatment-naive juvenile dermatomyositis reveals mitochondrial abnormalities despite disease-related interferon-driven signature.
Journal: Annals of the rheumatic diseases
Published: February 05, 2025
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers.
Journal: Rheumatology (Oxford, England)
Published: November 04, 2024
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus.
Journal: Clinical and experimental immunology
Published: October 27, 2024
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.
Journal: Nature reviews. Rheumatology
Published: April 06, 2023
The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus.
Journal: Frontiers in immunology
Published: November 01, 2021
Juvenile dermatomyositis. Where are we now?
Journal: Clinical and experimental rheumatology
Published: October 01, 2021
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Journal: Science (New York, N.Y.)
Published: July 31, 2020
Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies.
Journal: Rheumatology (Oxford, England)
Published: March 05, 2019
B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.
Journal: Frontiers in immunology
Published: November 12, 2018
CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α.
Journal: Frontiers in immunology
Published: January 30, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026